Evidence map›Paper›PMID 30388200›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2020

Telomeres Increasingly Develop Aberrant Structures in Aging Humans.

Virginia Boccardi, Luigi Cari, Giuseppe Nocentini, Carlo Riccardi, Roberta Cecchetti, Carmelinda Ruggiero, Beatrice Arosio, Giuseppe Paolisso, Utz Herbig, Patrizia Mecocci

Open access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Association of Telomere Length with Cognitive Impairment.Journal of molecular neuroscience : MN · 2023
    Article
  4. Article
  5. Article
  6. Are Biological Consequences of Childhood Exposures Detectable in Telomere Length Decades Later?The journals of gerontology. Series A, Biological sciences and medical sciences · 2021
    Article
  7. Genome-Protecting Compounds as Potential Geroprotectors.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Virginia BoccardiDepartment of Medicine, Section of Gerontology and Geriatrics, Santa Maria della Misericordia Hospital.
Luigi CariDepartment of Medicine, Section of Pharmacology, University of Perugia.
Giuseppe NocentiniDepartment of Medicine, Section of Pharmacology, University of Perugia.
Carlo RiccardiDepartment of Medicine, Section of Pharmacology, University of Perugia.
Roberta CecchettiDepartment of Medicine, Section of Gerontology and Geriatrics, Santa Maria della Misericordia Hospital.
Carmelinda RuggieroDepartment of Medicine, Section of Gerontology and Geriatrics, Santa Maria della Misericordia Hospital.
Beatrice ArosioGeriatric Unit, Fondazione Ca' Granda, IRCCS Ospedale Maggiore Policlinico, Milan.
Giuseppe PaolissoDepartment of Medical, Surgical, Neurologic, Metabolic and Aging Sciences, University of Campania "Luigi Vanvitelli," Naples, Italy.
Utz HerbigDepartment of Microbiology, Biochemistry and Molecular Genetics, New Jersey Medical School-Cancer Center, Rutgers Biomedical and Health Sciences, Newark.
Patrizia MecocciDepartment of Medicine, Section of Gerontology and Geriatrics, Santa Maria della Misericordia Hospital.
Misericordia University · USUniversity of Perugia · ITRutgers, The State University of New Jersey · USUniversity of Campania "Luigi Vanvitelli" · ITUniversity of Milan · IT

Funding

Tumor Suppression by Telomere Dysfunction Induced SenescenceR01CA136533 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI HERBIG, UTZ · 2010 to 2021
$3.7M
(PQB-4) Opposing Effects of the SASP in Cancer ProgressionR01CA184572 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI HERBIG, UTZ · 2014 to 2017
$1.3M
NCI NIH HHS R01 CA136533NCI NIH HHS R01 CA184572
6 · The paper itself

Abstract

Telomeres progressively shorten with age, and it has been proposed that critically short and dysfunctional telomeres contribute to aging and aging-associated diseases in humans. For many years it was thought that telomere erosion was strictly a consequence of the "end replication problem," or the inability of replicative polymerases to completely duplicate linear DNA ends. It is becoming increasingly evident, however, that telomere shortening of cultured human cells is also caused because of other replication defects in telomeric repeats, those that cause fragile telomeres and other aberrant telomeric structures that can be detected on metaphase chromosomes. Whether these replication defects contribute to telomere erosion also in human tissues is currently unknown. By analyzing peripheral blood mononuclear cells from a total of 35 healthy subjects ranging in age from 23 to 101 years, we demonstrated that telomeres increasingly display aberrant structures with advancing donor age. Although the percentages of fragile telomeres increased only until adulthood, the percentages of chromosomes displaying sister telomere loss and sister telomere chromatid fusions increased consistently throughout the entire human life span. Our data, therefore, suggest that telomeric replication defects other than the end replication problem contribute to aging-associated telomere erosion in humans.

Indexed as

AdultAgedAged, 80 and overAgingFemaleHealthy VolunteersHumansIn Situ Hybridization, FluorescenceLeukocytes, MononuclearMaleMiddle AgedPolymerase Chain ReactionTelomereTelomere ShorteningHealthHuman agingTelomeres

Identifiers

PMID30388200
PMCPMC7176058
OpenAlexW2899509749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.